Studying multiple myeloma across racial and ethnic groups in California
Surveys people with multiple myeloma from several ethnic groups about factors affecting disease.
Key facts
- Who runs it
- University of California, Davis
- Where
- Sacramento, United StatesSee the site
- Trial code
- Registry title
- Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
- Status
- Recruiting
- People taking part
- 4,000 people, planned
- Started
- 1 Sept 2020
- Expected to end
- 30 Dec 2026
- Type of study
- Observational
- Record updated
- 14 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults in California who were diagnosed with multiple myeloma in the past 5 years and are still alive. They must be African American, Latino, Asian American/Native Hawaiian/Pacific Islander, or non-Hispanic White.
- Age
- At least 21 years old at the time of diagnosis.
- Sex
- All sexes can join.
- Disease stage
- A first primary multiple myeloma confirmed by pathology, diagnosed within the previous 5 years.
Main reasons for not taking part
- Never diagnosed with multiple myeloma
- Under the age of 21
- Pregnant
- Prisoner
- Diagnosed outside the 48 California counties of the study
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Diagnosed with a first primary pathologically confirmed case of Multiple Myeloma within the previous 5 years
- At least 21 years of age at the time of diagnosis
- Must have been diagnosed in one of the 48 counties in California
- Participant must be alive
- Identify as one of the following: African American, Latino, Asian American/Native Hawaiian/Pacific Islander, Non-Hispanic White
Who cannot take part
- Under the age of 21
- People who have not been diagnosed with Multiple Myeloma
- Pregnant
- Prisoner
Where in United States
- University of California Davis Comprehensive Cancer CenterSacramento, United StatesContact: Luis Carvajal-Carmona, PhDTaking people
About the trial
What the trial wants to find out
The objectives of the proposed study are to develop and evaluate protocols for ethnic/racial minority-specific research using cancer registry data. In conjunction with the Cancer Registry of Greater California (CRGC), the investigators have developed procedures to identify, recruit, and survey ethnic/racial minority patients with MM. To pilot the study, the investigators aim initially to test the feasibility of this protocol by contacting 400 eligible patients (100 African Americans, 100 Latinos, 100 Asian American/Native Hawaiian/Pacific Islander-AANHPI and 100 non-Hispanic Whites as a comparison group) to conduct a pilot survey through which will ascertain etiological and survival-related factors for MM. Ultimately, the investigators hope the findings from this pilot will yield insight into the best practices for recruiting minorities with MM and serve as the basis for larger population-based studies of MM etiology and survival.
Read full original descriptionShow less
The next phase of this study is to expand the study to all 3 California Cancer Registries, including the Greater Bay Area Cancer Registry and the Los Angeles Cancer Surveillance Program and Cancer Registry of Greater California. We will increase the sample size to recruit atleast 1000 participants per racial/ethnic group. We will also request to increase the scope of the study to also continue a survivorship cohort.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
- Plain-language title
- Studying multiple myeloma across racial and ethnic groups in CaliforniaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 14 September 2026